The invention consists of the use of the HIP/PAP protein or a protein derivative thereof for preventing or treating a disease selected from the group consisting of a neonatal brain injury, an adult brain injury caused by a brain hypoxia and a disease involving a defect in the production or in the phosphorylation of Gap-43.